Filter
1234
Text search:
human
pharmaceutical
products
Featured
Recommendations
118
New Publications
332
Language
Document type
No document type
595
Studies & Reports
263
Guidelines
192
Manuals
72
Strategic & Response Plan
69
Training Material
15
Fact sheets
13
Situation Updates
8
Resource Platforms
4
Brochures
2
Infographics
1
Countries / Regions
Kenya
60
Global
51
Ethiopia
40
India
37
Nigeria
27
South Africa
27
Sierra Leone
26
Western and Central Europe
26
Uganda
24
Liberia
23
Rwanda
22
Ghana
21
Namibia
20
Zambia
18
Tanzania
18
Ukraine
17
Philippines
15
Africa
15
Nepal
14
Bangladesh
12
Malawi
12
Latin America and the Carribbean
12
Eastern Europe
12
Zimbabwe
11
Indonesia
11
Lesotho
9
Myanmar / Burma
9
Eswatini/ Swaziland
8
West and Central Africa
7
Burkina Faso
6
Syria
6
Botswana
6
Eastern Europe and Central Asia
6
Asia
6
Cambodia
5
East and Southern Africa
5
Senegal
4
Congo, Democratic Republic of
4
Cameroon
4
Haiti
4
South–East Asia Region
4
Guinea
3
Jordan
3
Thailand
3
Mozambique
3
Sudan
3
North Macedonia
3
Venezuela
3
Russia
3
North America
3
Mali
2
USA
2
Pakistan
2
South Sudan
2
China
2
Benin
2
Central African Republic
2
Brazil
2
Middle East and North Africa
2
Fiji
2
Albania
2
Laos
2
Moldova
2
Kyrgyzstan
2
Georgia
2
Vietnam
2
Jamaica
2
Saudi Arabia
1
Niger
1
Somalia
1
Iraq
1
Afghanistan
1
Germany
1
Lebanon
1
Egypt
1
Papua New Guinea
1
Serbia
1
Libya
1
Madagascar
1
Western Pacific Region
1
Armenia
1
Timor Leste/ East Timor
1
Tajikistan
1
Bulgaria
1
Iran
1
Uzbekistan
1
Australia
1
Kazakhstan
1
Gabon
1
Denmark
1
Maldives
1
United Kingdom
1
Authors & Publishers
Publication Years
Category
Countries
504
Clinical Guidelines
89
Key Resources
64
Public Health
59
Women & Child Health
33
Pharmacy & Technologies
24
Capacity Building
9
Annual Report MEDBOX
1
Toolboxes
AMR
159
Pharmacy
130
COVID-19
72
TB
57
HIV
51
Mental Health
46
Planetary Health
38
NTDs
34
Rapid Response
28
Global Health Education
26
Conflict
22
NCDs
22
Caregiver
20
Health Financing Toolbox
19
Ebola & Marburg
17
2.0 Rapid Response
15
Malaria
13
Disability
9
Refugee
7
Specific Hazards
6
Polio
5
Natural Hazards
5
Zika
3
The revised guidelines contain recommendations for specific administrative, environmental controls and respiratory protection, following the assessment made by an external group of experts convened as members of the Guideline Development Group. Moreover, these guidelines focus on interventions speci
...
The report reflects on the trends, achievements and challenges in global health over the past decade during which Dr Margaret Chan has been Director-General of WHO. It discusses the role of WHO in dealing with such issues as the rise of noncommunicable diseases, leaps in life expectancy, and emergin
...
The new WHO recommendations for the treatment of isoniazid-resistant, rifampicin-susceptible TB are based upon a review of evidence from patients treated with such regimens by a Guideline Development Group in conformity with WHO requirements for evidence-based policies.
A series of tools and templates have been developed by WHO, FAO and OIE to accompany the manual for developing national action plans on antimicrobial resistance
Health Systems in Transition. Vol. 5 No.3 2015
Kenya Policy: 2014-2030
recommended
Towards attaining the highest standard Health.
Interim policy guidance
The Council was established in late 2020 by Dr Tedros Adhanom
Ghebreyesus (Director-General, WHO) to provide new economic thinking – reassessing how health and wellbeing are valued, produced and distributed across the economy. An all-female group of 10 distinguished economists and area experts, t
...
The National Strategic Plan on Malaria Prevention and Elimination Period 2021 – 2025 seeks to build on the previous national successes of the National Institute of Malariology, Parasitology, and Entomology (NIMPE) while addressing current challenges to reduce the overall burden of malaria in the S
...
WHO guideline on balanced national controlled medicines policies to ensure medical access and safety
Access to medicines is essential for attainment of universal health coverage, which is central to achievement of the health-related Sustainable Development Goals. Controlled medicines include those such as opioids, benzodiazepines, barbiturates, amphetamines and others with identified or emergent cl
...
Healthcare Waste Management Toolkit for Global Fund Practitioners and Policy Makers. Part B
This guideline is intended to provide recommendations to applicants wishing to submit applications for the registration of medicines. It represents the Medicines Control Council’s current thinking on the safety, quality and efficacy of medicines.